Effect of intraventricular injection of 5,7-dihydroxytryptamine on regional tryptophan hydroxylase of rat brain |
| |
Authors: | H. G. Baumgarten S. J. Victor W. Lovenberg |
| |
Affiliation: | Section on Biochemical Pharmacology, Experimental Therapeutics Branch, National Heart and Lung Institute, Bethesda, Md 20014, U.S.A. |
| |
Abstract: | 5,6-DIHYDROXYTRYPTAMINE has been shown to cause selective degeneration of serotonergic neurons in the central nervous sytem (BAUMGARTEN, LACHENMAYER and SCHLOSSBERGER, 1972b). This degeneration is accompanied by depletion of serotonin (BAUMGARTEN et al., 1971; 1972a) and loss of tryptophan hydroxylase activity (VICTOR, BAUMGARTEN and LOVENBERG, 1973) in certain regions of the brain. In the current experiments, the effect of 5,7-dihydroxytryptamine (another dihydroxylated tryptamine derivative) on tryptophan hydroxylase activity has been examined. Since tryptophan hydroxylase is the rate-limiting enzyme in serotonin biosynthesis and has a similar distribution to that of serotonin in the brain, it is used as a biochemical marker of serotonergic neurons, Recent experiments also indicate that 5,7-dihydroxytryptamine causes morphological damage to serotonergic neurons of the central nervous system (BAUMGARTEN and LACHENMAYER, 1972). |
| |
Keywords: | |
|
|